Regeneron Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Regeneron Pharmaceuticals, Inc.‘s stocks are currently a part of 1048 hedge funds’ portfolios, which represents 81.29% of the total amount of its stocks outstanding. This makes up a total of 91.20M shares of Regeneron Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by 1.30% or 1.17M shares more. As for the holding position changes, 35.31% (370) of current hedge fund investors increased the number of shares held, 37.21% (390) of current holders sold a part of the shares held, and 10.21% (107) closed the holdings completely. 126 hedge funds are new holders of Regeneron Pharmaceuticals, Inc. stock in Q1 2022, it is 12.02% of total holders.
Hedge funds holding Regeneron Pharmaceuticals (Q2 2017 – Q1 2022)
| Q2 2017 | 597 |
|---|---|
| Q3 2017 | 597 |
| Q4 2017 | 629 |
| Q1 2018 | 608 |
| Q2 2018 | 611 |
| Q3 2018 | 630 |
| Q4 2018 | 657 |
| Q1 2019 | 700 |
| Q2 2019 | 644 |
| Q3 2019 | 617 |
| Q4 2019 | 684 |
| Q1 2020 | 793 |
| Q2 2020 | 909 |
| Q3 2020 | 887 |
| Q4 2020 | 877 |
| Q1 2021 | 888 |
| Q2 2021 | 942 |
| Q3 2021 | 988 |
| Q4 2021 | 1,049 |
| Q1 2022 | 1,048 |
Hedge funds changes in Regeneron Pharmaceuticals positions (Q2 2017 – Q1 2022)
| Q2 2017 | 82 | 229 | 198 | 51 | 37 |
|---|---|---|---|---|---|
| Q3 2017 | 73 | 223 | 209 | 68 | 24 |
| Q4 2017 | 113 | 233 | 197 | 72 | 14 |
| Q1 2018 | 82 | 220 | 208 | 99 | -1 |
| Q2 2018 | 68 | 236 | 209 | 60 | 38 |
| Q3 2018 | 81 | 215 | 220 | 55 | 59 |
| Q4 2018 | 110 | 223 | 223 | 83 | 18 |
| Q1 2019 | 110 | 308 | 185 | 62 | 35 |
| Q2 2019 | 67 | 239 | 251 | 109 | -22 |
| Q3 2019 | 53 | 249 | 211 | 80 | 24 |
| Q4 2019 | 134 | 200 | 247 | 54 | 49 |
| Q1 2020 | 193 | 272 | 251 | 78 | -1 |
| Q2 2020 | 200 | 377 | 234 | 73 | 25 |
| Q3 2020 | 103 | 364 | 309 | 118 | -7 |
| Q4 2020 | 138 | 363 | 276 | 139 | -39 |
| Q1 2021 | 130 | 371 | 279 | 113 | -5 |
| Q2 2021 | 151 | 358 | 292 | 89 | 52 |
| Q3 2021 | 129 | 401 | 314 | 74 | 70 |
| Q4 2021 | 168 | 419 | 312 | 95 | 55 |
| Q1 2022 | 126 | 370 | 390 | 107 | 55 |
Hedge funds changes in Regeneron Pharmaceuticals stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 183,304,579,516 | 57,436,828,148 |
|---|---|---|
| Q3 2017 | 25,975,260,110 | 114,247,169,127 |
| Q4 2017 | 92,230,649,708 | 272,266,811,352 |
| Q1 2018 | 110,593,809,948 | 261,860,708,440 |
| Q2 2018 | 7,565,541,257 | 88,893,087,343 |
| Q3 2018 | 755,588,172 | 1,155,878,688 |
| Q4 2018 | 754,980,050 | 993,475,600 |
| Q1 2019 | 505,278,222 | 791,456,892 |
| Q2 2019 | 517,522,900 | 650,211,100 |
| Q3 2019 | 496,958,420 | 555,229,980 |
| Q4 2019 | 773,412,140 | 912,595,304 |
| Q1 2020 | 31,042,184,905 | 6,958,777,812 |
| Q2 2020 | 1,077,482,760 | 31,082,397,235 |
| Q3 2020 | 911,970,860 | 954,153,068 |
| Q4 2020 | 3,831,017,861,577 | 2,509,285,063,151 |
| Q1 2021 | 917,261,920 | 1,374,566,358 |
| Q2 2021 | 1,043,192,414 | 1,252,353,928 |
| Q3 2021 | 1,157,681,038 | 1,441,223,776 |
| Q4 2021 | 984,676,408 | 1,476,931,640 |
| Q1 2022 | 686,705,000 | 1,104,003,514 |